Understanding breast cancer risk factors and outcomes in Florida

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the varying risk factors and outcomes associated with breast cancer among individuals in Florida. It involves collecting biospecimens, surgical tissue, and survey data from patients with BIRADS classifications 0-5 who are seen at designated breast radiology clinics. The study will include both men and women aged 18 and older who are new patients at the participating centers. By analyzing this data, researchers hope to gain insights into the reasons behind different breast cancer risks and outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy.
* Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.
* Men and women 18 years of age and older are eligible to participate in the study.

Exclusion Criteria:

* Patients who are less than 18 years of age will be considered ineligible.
* Patients unable to complete the survey.

Where it's running

• University of Miami (Data Collection Only)
  Miami, Florida, United States Recruiting
• Memorial Sloan Kettering Cancer Center (All protocol activites)
  New York, New York, United States Recruiting
• University of California, Los Angeles (Specimen Analysis only)
  Los Angeles, California, United States Not yet recruiting

Study contacts

• Principal investigator: Neha Goel, MD, MPH — Memorial Sloan Kettering Cancer Center
• Study coordinator: Neha Goel, MD, MPH
• Email: goeln1@mskcc.org
• Phone: 646-888-4731

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy

  This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.

  Recruiting at 24 sites Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Aviano and 23 other locations · NCT06805812

• 68Ga-FAPI-46 versus 18F-FDG PET imaging in ER-positive breast cancer

  This test compares whether 68Ga-FAPI-46 PET scans find more cancer spread than standard 18F-FDG PET scans in people with ER-positive breast cancer who need staging.

  Recruiting Phase 2 Maastricht University Medical Center · Maastricht · NCT06335069

• Dalpiciclib plus hormone therapy for early HR+/HER2- breast cancer

  This trial tests whether adding dalpiciclib at two different doses and durations to standard hormone therapy helps people with early HR+/HER2- breast cancer.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian and 1 other locations · NCT07581834

• ATUSA 3D automated breast ultrasound for suspicious breast lesions

  This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.

  Recruiting at 2 sites iSono Health, Inc. · Sacramento, California and 1 other locations · NCT07505797

• Benchmark and performance test for AI reading breast ultrasound images

  This project will test whether multimodal AI models can read breast ultrasound images to help classify normal, benign, and malignant findings for people who have had breast ultrasound.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT07500428

• Prehabilitation plus ongoing exercise and nutrition support for women with breast cancer

  This trial will test whether a short supervised pre-treatment program of high-intensity exercise and personalized nutrition followed by home-based exercise and dietary guidance helps newly diagnosed women with stage 0–III breast cancer recover better and tolerate treatment.

  Recruiting at 2 sites European University Miguel de Cervantes · Valladolid, Valladolid and 1 other locations · NCT07467824

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.